Affordable Access

Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing.

Authors
Type
Published Article
Journal
Effective clinical practice : ECP
Publication Date
Volume
4
Issue
5
Pages
214–220
Identifiers
PMID: 11685979
Source
Medline
License
Unknown

Abstract

In clinical trials with short PTCA-related delays, PTCA produced better outcomes, while trials with longer delays favored thrombolytic therapy. A more precise estimate of the time interval to equipoise between the two therapies needs to be modeled with patient-level data. At experienced cardiac centers, PTCA is probably still preferable, even with delays longer than 50 minutes.

Statistics

Seen <100 times